| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 50,254 | 55,261 | 59,449 | 65,837 | | Cost of Revenue | 6,659 | 9,307 | 13,386 | 15,744 | | | Gross Profit | 43,595 | 45,954 | 46,063 | 50,093 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 7,338 | 4,197 | 4,825 | 4,869 | | Non Recurring |
-
|
-
| 103,582 | 246,641 | | Others | 18,516 | 18,846 | 32,471 | 38,654 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,228 | 22,911 | (94,815) | (240,071) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (594) | (2,339) | (2,485) |
-
| | Earnings Before Interest And Taxes | 1,634 | 20,572 | (97,300) | (240,071) | | Interest Expense | 3,531 | 3,388 | 3,176 | 2,829 | | Income Before Tax | (1,897) | 17,184 | (100,476) | (242,900) | | Income Tax Expense | 7,876 | 8,151 | (34,799) | (89,391) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (9,773) | 9,033 | (65,677) | (153,509) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 5,740 | 9,033 | (65,677) | (153,509) | | Preferred Stock And Other Adjustments | (1,287) | (1,287) | (1,280) | (1,285) | | | Net Income Applicable To Common Shares | $4,453 | $7,746 | ($66,957) | ($154,794) |
|
0.02% Nasdaq 
0.07%
Income Statement
